| dbo:abstract
|
- COVID-19 vaccination in mainland China is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mainland China, in response to the ongoing pandemic in the region. As of July 2022, it is estimated that about 89.7% of the country's population has received a vaccine, and about 56% of the population has received a booster dose. (en)
- 中国大陆2019冠状病毒病疫苗接种计划，是指由中华人民共和国大陆的各地区执行的2019冠状病毒病疫苗大规模接种计划，其目标为符合条件的民众，可以到经当地卫生健康行政部门设置的接种地点免费接种疫苗，在人群中逐步建立起免疫屏障，以阻断2019冠状病毒病的流行。截至2021年6月，中国大陆共有7款疫苗批准附条件上市或紧急使用，可以供接种单位接种。2021年3月，启动针对海外中国公民的春苗行动。 (zh)
|
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 30763 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:caption
|
- COVID-19 vaccine doses administered in mainland China. (en)
|
| dbp:cause
| |
| dbp:date
| |
| dbp:target
|
- Immunization against COVID-19 (en)
|
| dbp:title
|
- COVID-19 vaccination in mainland China (en)
|
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdfs:comment
|
- COVID-19 vaccination in mainland China is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mainland China, in response to the ongoing pandemic in the region. As of July 2022, it is estimated that about 89.7% of the country's population has received a vaccine, and about 56% of the population has received a booster dose. (en)
- 中国大陆2019冠状病毒病疫苗接种计划，是指由中华人民共和国大陆的各地区执行的2019冠状病毒病疫苗大规模接种计划，其目标为符合条件的民众，可以到经当地卫生健康行政部门设置的接种地点免费接种疫苗，在人群中逐步建立起免疫屏障，以阻断2019冠状病毒病的流行。截至2021年6月，中国大陆共有7款疫苗批准附条件上市或紧急使用，可以供接种单位接种。2021年3月，启动针对海外中国公民的春苗行动。 (zh)
|
| rdfs:label
|
- COVID-19 vaccination in mainland China (en)
- 中国大陆2019冠状病毒病疫苗接种计划 (zh)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
